Mimedx (MDXG) Net Margin (2011 - 2026)

Mimedx has disclosed Net Margin across 15 years of filings, most recently posting 18.41% for Q1 2026.

• Net Margin for Q1 2026 came in at 18.41%, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was 2.79% (down 1214.0% YoY), and the FY2025 annual result was 11.6%, down 43.0% from the prior year.
• Net Margin came in at 18.41% for Q1 2026 at Mimedx, down from 8.01% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 51.63% in Q4 2023 to a low of 20.5% in Q1 2022.
• The 4-year median for Net Margin is 8.65% (2023), against an average of 3.94%.
• Across the five-year window, Net Margin jumped 4069 bps in 2023 and plunged 4362 bps in 2024, its largest moves.
• Mimedx's Net Margin stood at 10.94% in 2022, then jumped by 372 bps to 51.63% in 2023, then tumbled by 84 bps to 8.01% in 2024, then sank by 330 bps to 18.41% in 2026.
• The last three Net Margin figures came in at 18.41% (Q1 2026), 8.01% (Q4 2024), and 9.37% (Q3 2024), per Business Quant data.